Dr. Bertha Caridad Fonseca M.D.

Recommended Articles

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...

• Knocking Out Parkinson's: How Boxing is Effective for Parkinson's Patients

  Parkinson’s disease is a progressive disorder of the central system that primarily affects the motor system and movement capabilities of the patients. The symptoms of Parkinson’s disease usually appear slowly overtime but are generally dominated by shaking, rigidity, slowness when patients try...

• Reports Estimate Alzheimer's Treatment to Skyrocket for Patients and Caregivers

  In the United States, the healthcare system, trained caregivers and medical personnel attempt to give the best possible standards of care for their citizens. From the most complicated diseases and ailments like Alzheimer’s, Parkinson’s, or fibromyalgia, to simple conditions such as the common...

• New Research Disproves Link Between Alzheimer's and Heartburn Drugs

  Previous studies have found an association between common heartburn medications and an increased risk of AD. However, more recent studies have reached other conclusions.A group of researchers from Germany found that proton pump inhibitors (PPIs), including commonly used medications such as Nexium,...

• Communicating with an Alzheimer's Patient

  Many aspects have been focused on and taken into consideration when it comes to Alzheimer's research. Additional studies that support and give a better understanding, list acceptance, and encourage a positive outlook are important for those with Alzheimer's. Although the disease does indeed progress...

• Botox May Be a Treatment Option for Migraines

  The National Institute for Health and Clinical Excellence (NICE), has prepared the draft guidance recommending the use of Botox or botulinum toxin type A in the treatment of migraine. According to this guidance, the injections should be stopped if the person has episodic migraine or if the...